Explore Our Network
Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.
Showing 2 Patents
Antisense compounds targeting Leucine-Rich repeat kinase 2(LRRK2) for the treatment of Parkinsons disease
29-09-2020 • US-10787669-B2
HASTINGS, MICHELLE L. • ISACSON, OLE • KORECKA-ROET, JOANNA A.
Rosalind Franklin University of Medicine and Science • Mclean Hospital Corp
Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease
06-08-2019 • US-10370667-B2
HASTINGS, MICHELLE L. • ISACSON, OLE • KORECKA-ROET, JOANNA A.
Rosalind Franklin University of Medicine and Science • Mclean Hospital Corp